| P50 | author | Kuen-Jer Tsai | Q48943781 |
| P2093 | author name string | Yoshihito Hayashi | |
| | Cheng-Che Lee | |
| | Huan-Ting Lin | |
| P2860 | cites work | Human Neural Stem Cells Reinforce Hippocampal Synaptic Network and Rescue Cognitive Deficits in a Mouse Model of Alzheimer's Disease | Q91421961 |
| | Questions EMERGE as Biogen claims aducanumab turnaround | Q91560063 |
| | Sodium oligomannate therapeutically remodels gut microbiota and suppresses gut bacterial amino acids-shaped neuroinflammation to inhibit Alzheimer's disease progression | Q93134029 |
| | Correlative Memory Deficits, Abeta Elevation, and Amyloid Plaques in Transgenic Mice | Q22242267 |
| | Medial ganglionic eminence-like cells derived from human embryonic stem cells correct learning and memory deficits | Q24598809 |
| | Induced pluripotent stem cells in Alzheimer's disease: applications for disease modeling and cell-replacement therapy | Q26749360 |
| | Potential of Neural Stem Cell-Based Therapy for Parkinson's Disease | Q26776154 |
| | Cancer stem cells in brain tumors and their lineage hierarchy | Q26992115 |
| | Inconsistencies and controversies surrounding the amyloid hypothesis of Alzheimer's disease | Q27003841 |
| | Gain of BDNF Function in Engrafted Neural Stem Cells Promotes the Therapeutic Potential for Alzheimer's Disease. | Q27345509 |
| | The antibody aducanumab reduces Aβ plaques in Alzheimer’s disease | Q28005463 |
| | Choices for Induction of Pluripotency: Recent Developments in Human Induced Pluripotent Stem Cell Reprogramming Strategies | Q28085565 |
| | Neuropathologic changes in Alzheimer's disease | Q28203182 |
| | Delayed increase of Ca2+ influx elicited by glutamate: role in neuronal death | Q28257073 |
| | Triple-transgenic model of Alzheimer's disease with plaques and tangles: intracellular Abeta and synaptic dysfunction | Q29547778 |
| | Isolation of multipotent neural stem or progenitor cells from both the dentate gyrus and subventricular zone of a single adult mouse. | Q30539757 |
| | Neural Stem Cell Transplant-Induced Effect on Neurogenesis and Cognition in Alzheimer Tg2576 Mice Is Inhibited by Concomitant Treatment with Amyloid-Lowering or Cholinergic α7 Nicotinic Receptor Drugs | Q30659307 |
| | Age-dependent changes in brain, CSF, and plasma amyloid (beta) protein in the Tg2576 transgenic mouse model of Alzheimer's disease. | Q31840691 |
| | Stem Cells Transplantation and Huntington's Disease | Q33614689 |
| | The familial Alzheimer's disease APPV717I mutation alters APP processing and Tau expression in iPSC-derived neurons | Q33725851 |
| | Neural stem cells genetically-modified to express neprilysin reduce pathology in Alzheimer transgenic models | Q33746410 |
| | Drugs for Alzheimer's disease: are they effective? | Q33865325 |
| | Memantine: a NMDA receptor antagonist that improves memory by restoration of homeostasis in the glutamatergic system--too little activation is bad, too much is even worse | Q34007194 |
| | Combined effect of nerve growth factor and brain‑derived neurotrophic factor on neuronal differentiation of neural stem cells and the potential molecular mechanisms | Q34105254 |
| | Current and future treatments for Alzheimer's disease | Q34646921 |
| | Abeta42-driven cerebral amyloidosis in transgenic mice reveals early and robust pathology | Q35016226 |
| | Chemokine receptors: signposts to brain development and disease | Q35141737 |
| | A combination Alzheimer's therapy targeting BACE1 and neprilysin in 5XFAD transgenic mice | Q35426661 |
| | Cumulative, additive benefits of memantine-donepezil combination over component monotherapies in moderate to severe Alzheimer's dementia: a pooled area under the curve analysis | Q35620305 |
| | Neural stem cell transplantation at critical period improves learning and memory through restoring synaptic impairment in Alzheimer's disease mouse model | Q36347323 |
| | Human neural stem cells improve cognition and promote synaptic growth in two complementary transgenic models of Alzheimer's disease and neuronal loss | Q36490240 |
| | Effect of Astragaloside IV on Neural Stem Cell Transplantation in Alzheimer's Disease Rat Models | Q36725913 |
| | Neural stem cells improve cognition via BDNF in a transgenic model of Alzheimer disease. | Q37273874 |
| | In Vivo Tracking of Human Neural Progenitor Cells in the Rat Brain Using Magnetic Resonance Imaging Is Not Enhanced by Ferritin Expression | Q37315468 |
| | Human Neural Stem Cell Transplantation Rescues Cognitive Defects in APP/PS1 Model of Alzheimer's Disease by Enhancing Neuronal Connectivity and Metabolic Activity | Q37430416 |
| | HuCNS-SC Human NSCs Fail to Differentiate, Form Ectopic Clusters, and Provide No Cognitive Benefits in a Transgenic Model of Alzheimer's Disease. | Q37644720 |
| | Maintenance and differentiation of neural stem cells | Q37808164 |
| | Progress in stem cell therapy for major human neurological disorders. | Q38107439 |
| | Induced neural stem cells (iNSCs) in neurodegenerative diseases | Q38110478 |
| | Vaccination against Alzheimer disease: an update on future strategies | Q38188866 |
| | Drug treatments in Alzheimer's disease. | Q38850887 |
| | Production of neural stem cells from human pluripotent stem cells | Q38963472 |
| | Neural stem cell therapy for neurodegenerative disorders: The role of neurotrophic support. | Q39144600 |
| | Neural stem cell replacement: a possible therapy for neurodevelopmental disorders? | Q39490571 |
| | Neural stem cell transplantation decreases neuroinflammation in a transgenic mouse model of Alzheimer's disease | Q40365868 |
| | The Crossroads of Neural Stem Cell Development and Tumorigenesis | Q41283587 |
| | Developing neural stem cell-based treatments for neurodegenerative diseases | Q41547468 |
| | Neural stem cell transplantation enhances mitochondrial biogenesis in a transgenic mouse model of Alzheimer's disease-like pathology | Q41591159 |
| | Modeling familial Alzheimer's disease with induced pluripotent stem cells | Q42817521 |
| | Stem Cell Tracking Technologies for Neurological Regenerative Medicine Purposes. | Q43375861 |
| | Neural stem cell transplantation improves spatial learning and memory via neuronal regeneration in amyloid-β precursor protein/presenilin 1/tau triple transgenic mice | Q43494602 |
| | Neural stem cell transplantation in mouse brain | Q43798772 |
| | Changes in amyloid-β and Tau in the cerebrospinal fluid of transgenic mice overexpressing amyloid precursor protein | Q43861573 |
| | Intraneuronal Abeta causes the onset of early Alzheimer's disease-related cognitive deficits in transgenic mice | Q44182586 |
| | Neural stem cells improve memory in an inducible mouse model of neuronal loss. | Q44339825 |
| | Mutation screening of the tau gene in patients with early-onset Alzheimer's disease | Q44468725 |
| | Effects of neural stem cells on synaptic proteins and memory in a mouse model of Alzheimer's disease | Q44763772 |
| | Effective drug therapy for Alzheimer's disease remains elusive | Q45148787 |
| | Embryonic stem cell-derived neural precursor cells improve memory dysfunction in Abeta(1-40) injured rats | Q46805283 |
| | Trial of Solanezumab for Mild Dementia Due to Alzheimer's Disease | Q47552349 |
| | Reprogramming of somatic cells to induced neural stem cells | Q47645196 |
| | Stem cell transplantation for Huntington's diseases | Q47722179 |
| | Towards stem cell based therapies for Parkinson's disease | Q47877645 |
| | Alzheimer's disease in the 100 years since Alzheimer's death | Q47918885 |
| | Transplantation of NSC-derived cholinergic neuron-like cells improves cognitive function in APP/PS1 transgenic mice | Q48329246 |
| | Intraneuronal beta-amyloid aggregates, neurodegeneration, and neuron loss in transgenic mice with five familial Alzheimer's disease mutations: potential factors in amyloid plaque formation. | Q48404445 |
| | APPSw transgenic mice develop age-related A beta deposits and neuropil abnormalities, but no neuronal loss in CA1. | Q48629595 |
| | Thrombospondin-1 secreted by human umbilical cord blood-derived mesenchymal stem cells rescues neurons from synaptic dysfunction in Alzheimer's disease model | Q49367941 |
| | iPSC-Based Compound Screening and In Vitro Trials Identify a Synergistic Anti-amyloid β Combination for Alzheimer's Disease. | Q49793536 |
| | Motor deficits, neuron loss, and reduced anxiety coinciding with axonal degeneration and intraneuronal Aβ aggregation in the 5XFAD mouse model of Alzheimer's disease. | Q50681098 |
| | Neural stem cell transplants improve cognitive function without altering amyloid pathology in an APP/PS1 double transgenic model of Alzheimer's disease. | Q50692044 |
| | Behavioral characterization of the Tg2576 transgenic model of Alzheimer's disease through 19 months. | Q52012764 |
| | Current Perspectives regarding Stem Cell-Based Therapy for Alzheimer's Disease. | Q52568314 |
| | Ten years of progress and promise of induced pluripotent stem cells: historical origins, characteristics, mechanisms, limitations, and potential applications. | Q55314338 |
| | Human neural stem cell transplantation improves cognition in a murine model of Alzheimer's disease | Q57041817 |
| | Inflammation as a central mechanism in Alzheimer's disease | Q58555818 |
| | Trends in Alzheimer's Disease Research Based upon Machine Learning Analysis of PubMed Abstracts | Q90581926 |
| P433 | issue | 1 | |
| P921 | main subject | Alzheimer's disease | Q11081 |
| | neural stem cell | Q2944097 |
| | stem cell transplantation | Q65592366 |
| P304 | page(s) | 29 | |
| P577 | publication date | 2020-01-27 | |
| P1433 | published in | Journal of Biomedical Science | Q15759332 |
| P1476 | title | Effects of neural stem cell transplantation in Alzheimer's disease models | |
| P478 | volume | 27 | |